Catalyst Pharmaceuticals Inc (CPRX)
16.44
+0.32 (+1.99%)
USD |
NASDAQ |
Mar 27, 16:00
16.59
+0.15 (+0.91%)
After-Hours: 20:00
Catalyst Pharmaceuticals Cash from Operations (TTM): 116.05M for Dec. 31, 2022
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 116.05M |
| September 30, 2022 | 95.15M |
| June 30, 2022 | 75.55M |
| March 31, 2022 | 65.04M |
| December 31, 2021 | 60.37M |
| September 30, 2021 | 54.30M |
| June 30, 2021 | 44.04M |
| March 31, 2021 | 41.64M |
| December 31, 2020 | 45.03M |
| September 30, 2020 | 44.22M |
| June 30, 2020 | 49.03M |
| March 31, 2020 | 49.84M |
| December 31, 2019 | 34.61M |
| September 30, 2019 | 13.97M |
| June 30, 2019 | -9.247M |
| March 31, 2019 | -28.08M |
| December 31, 2018 | -26.15M |
| September 30, 2018 | -21.83M |
| June 30, 2018 | -17.51M |
| March 31, 2018 | -15.95M |
| December 31, 2017 | -13.74M |
| September 30, 2017 | -14.12M |
| June 30, 2017 | -14.77M |
| March 31, 2017 | -15.91M |
| December 31, 2016 | -17.96M |
| Date | Value |
|---|---|
| September 30, 2016 | -18.18M |
| June 30, 2016 | -20.25M |
| March 31, 2016 | -20.15M |
| December 31, 2015 | -18.02M |
| September 30, 2015 | -17.36M |
| June 30, 2015 | -15.57M |
| March 31, 2015 | -14.31M |
| December 31, 2014 | -12.94M |
| September 30, 2014 | -13.09M |
| June 30, 2014 | -11.22M |
| March 31, 2014 | -10.05M |
| December 31, 2013 | -9.876M |
| September 30, 2013 | -7.339M |
| June 30, 2013 | -6.756M |
| March 31, 2013 | -6.088M |
| December 31, 2012 | -5.140M |
| September 30, 2012 | -4.985M |
| June 30, 2012 | -5.136M |
| March 31, 2012 | -5.455M |
| December 31, 2011 | -4.985M |
| September 30, 2011 | -4.316M |
| June 30, 2011 | -3.881M |
| March 31, 2011 | -3.567M |
| December 31, 2010 | -3.757M |
| September 30, 2010 | -3.817M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-28.08M
Minimum
Mar 2019
116.05M
Maximum
Dec 2022
33.50M
Average
44.13M
Median
Cash from Operations (TTM) Benchmarks
| ADMA Biologics Inc | -59.51M |
| Ardelyx Inc | -70.04M |
| Rhythm Pharmaceuticals Inc | -173.43M |
| Merrimack Pharmaceuticals Inc | -1.742M |
| Jaguar Health Inc | -35.60M |